You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IIIA non-small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Blood Samples in Patients With Non-small Cell Lung Cancer

Recruiting
  • Stage III Non-Small Cell Lung Cancer AJCC v7
  • +3 more
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 18, 2022

Stage IIIA NSCLC Trial in Cleveland (Cisplatin, Etoposide, Pembrolizumab)

Terminated
  • Stage IIIA Non-Small Cell Lung Cancer
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Dec 15, 2022

Stage IIIB(N2) NSCLC, Stage IIA NSCLC, Stage IIB NSCLC Trial in Beijing (Pembrolizumab 200 mg IV infusion)

Not yet recruiting
  • Stage IIIB(N2) Non-small Cell Lung Cancer
  • +3 more
  • Pembrolizumab 200 mg IV infusion
  • Beijing, Beijing, China
    Peking University
May 30, 2023

NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Yangzhou, Jiangsu, China
    People's hospital of northern jiangsu
Sep 26, 2023

Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +3 more
  • therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
  • quality-of-life assessment
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

Active, not recruiting
  • Non-Squamous Non-Small Cell Lung Carcinoma
  • +7 more
  • Nivolumab
  • +3 more
  • Abington, Pennsylvania
  • +1 more
Sep 14, 2022

Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab

Terminated
Has Results
  • Mesothelin Positive
  • +4 more
  • Anetumab Ravtansine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jan 5, 2023

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

Stage IIIA NSCLC, Stage IIIB NSCLC Trial in United States (drug, procedure, radiation)

Recruiting
  • Stage IIIA Non-small Cell Lung Cancer
  • Stage IIIB Non-small Cell Lung Cancer
  • San Diego, California
  • +14 more
Dec 5, 2022

Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in

Recruiting
  • Stage I Non-Small Cell Lung Cancer AJCC v7
  • +6 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 2, 2022

Identify Resected Non-small-cell Lung Cancer With High Risk of

Recruiting
  • Non-small Cell Lung Cancer Stage IIIA
  • Resected non small cell lung cancer
  • Toulouse, France
    Julien MAZIERES
Feb 8, 2023

Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,

Recruiting
  • Extensive Stage Small Cell Lung Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +1 more
Jun 27, 2022

NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)

Recruiting
  • NSCLC
  • SBRT+LDRT
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 2, 2023

NSCLC Trial (V940, Pembrolizumab, Placebo)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • V940
  • +2 more
  • (no location specified)
Oct 5, 2023

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora

Completed
Has Results
  • Adenocarcinoma of the Lung
  • +7 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jan 19, 2022

Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell

Active, not recruiting
  • Stage I Lung Non-Small Cell Cancer AJCC v7
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 24, 2022

Solid Tumor, Stage III Pancreatic Cancer, Stage IIIA Breast Cancer Trial in Atlanta (Carboplatin, Cisplatin, Palbociclib)

Active, not recruiting
  • Solid Neoplasm
  • +16 more
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Non Small Cell Lung Cancer Trial (Tislelizumab, Ociperlimab, LBL-007)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • (no location specified)
Jan 30, 2023

Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in

Active, not recruiting
  • Stage IB Non-Small Cell Lung Carcinoma AJCC v7
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 4, 2022

NSCLC, Stage II-IIIA, Immunotherapy Trial in Shanghai (Serplulimab and Chemotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Serplulimab and Chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 27, 2023

Non Small Cell Lung Cancer, Stage I Lung Cancer, Stage Ib Lung Carcinoma Trial in Winston-Salem (Vitamin A Compound, Therapeutic

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Vitamin A Compound
  • Therapeutic Conventional Surgery
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Jan 5, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Anamorelin Hydrochloride, Placebo,

Active, not recruiting
  • Anorexia
  • +8 more
  • Anamorelin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Small Cell Carcinoma, Extensive Stage Lung Small Cell Carcinoma Trial in

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Best Practice
  • +5 more
  • Columbus, Ohio
    Carolyn Presley
Aug 30, 2022